Hürthle cell (Oncocytic) carcinoma – Is hemithyroidectomy enough?
Surgical Oncology Insight · 2024-03 · 1 (1) · 100010
DOI: 10.1016/j.soi.2024.100010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgical Oncology Insight, 2024-03. Verfasst von Taylor O. Julsrud und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Julsrud, T. O., Foster, T. R., Vierkant, R. A., Lyden, M. L., McKenzie, T. J., Ryder, M., & Dy, B. M. (2024). Hürthle cell (Oncocytic) carcinoma – Is hemithyroidectomy enough?. Surgical Oncology Insight, 1(1), 100010. https://doi.org/10.1016/j.soi.2024.100010
Vancouver
Julsrud TO, Foster TR, Vierkant RA, Lyden ML, McKenzie TJ, Ryder M, et al. Hürthle cell (Oncocytic) carcinoma – Is hemithyroidectomy enough?. Surgical Oncology Insight. 2024;1(1):100010. doi:10.1016/j.soi.2024.100010
BibTeX
@article{Julsrud2024,
author = {Julsrud, Taylor O. and Foster, Trenton R. and Vierkant, Robert A. and Lyden, Melanie L. and McKenzie, Travis J. and Ryder, Mabel and Dy, Benzon M.},
title = {Hürthle cell (Oncocytic) carcinoma – Is hemithyroidectomy enough?},
journal = {Surgical Oncology Insight},
year = {2024},
volume = {1},
number = {1},
pages = {100010},
doi = {10.1016/j.soi.2024.100010}
}
EUVIMED